Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials
Peter M. Rothwell(UK Dementia Research Institute), Ziyah Mehta, J. Michael Gaziano(VA Boston Healthcare System), Takeshi Morimoto(Hyogo Medical University), Nancy R. Cook(Brigham and Women's Hospital), Maria Carla Roncaglioni(Mario Negri Institute for Pharmacological Research), J. J. F. Belch(Ninewells Hospital)
Cited by 357
Related Papers
Assessing the Performance of Prediction Models
|Epidemiology|2009|4.9k
Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events
|New England Journal of Medicine|2002|3.6k
Lack of Effect of Long-Term Supplementation with Beta Carotene on the Incidence of Malignant Neoplasms and Cardiovascular Disease
|New England Journal of Medicine|1996|2.4k
C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events
|Circulation|2003|2.3k
Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction
|Circulation|2007|2.1k